Selecting a CRO is a major decision that can influence your entire program
After yielding positive results during pre-clinical testing, it’s time to prepare for a move into clinical trials. However, there are a few items to consider that can set your study up for success. Clinical Research Organization (CRO) selection involves much more than an assessment of their service offering. Indication experiences, familiarity with drug delivery mechanisms, and tangential laboratory support represent only a few of the important upfront criteria for developing your shortlist of potential partners.
The article below, published on PharmaLive, covers:
- Strategies to narrow your list of CROs
- Issuing a Request for Proposal (RFP)
- Scheduling a Bid Defense Meeting (BDM)
- Post-BDM follow-up discussions
- The typical selection process, and more
For deeper insights into finding the right partner and developing a successful relationship, click here.